ModivCare regains Nasdaq listing compliance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 10 2025
0mins
Should l Buy ?
Modivcare Compliance: Modivcare has regained compliance with Nasdaq regarding its market value of publicly held shares.
Confirmation from Nasdaq: On July 7, Nasdaq confirmed that Modivcare's market value had been above $15M for the last 20 consecutive business days, ensuring its continued listing.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
